| Dec 31,
2021 | Dec 31,
2022 | Dec 31,
2023 | Dec 31,
2024 |
|---|
| Net loss | -1,056,706 | 4 | 12 | -74 |
|---|
| Depreciation and amortization | - | - | - | 0 |
|---|
| Change in fair value of simple agreements for future equity | - | - | - | -28 |
|---|
| Accretion of discount on marketable debt securities | - | - | - | 1 |
|---|
| Stock-based compensation | - | - | - | 12 |
|---|
| Prepaid and other current assets | - | - | - | 2 |
|---|
| Other assets | - | - | - | 0 |
|---|
| Accounts payable | - | - | - | -2 |
|---|
| Accrued expenses and other | - | - | - | -2 |
|---|
| Operating lease right-of-use assets and liabilities | - | - | - | 0 |
|---|
| Net cash used in operating activities | -1,880,180 | -954,691 | -10,844,603 | -38 |
|---|
| Purchases of property and equipment | - | - | - | 0 |
|---|
| Purchases of marketable debt securities | - | - | - | 292 |
|---|
| Proceeds from redemptions of marketable debt securities | - | - | - | 116 |
|---|
| Net cash used in investing activities | -500,000,000 | 1 | 225 | -176 |
|---|
| Proceeds from recapitalization | - | - | - | 276 |
|---|
| Proceeds from Stock Options Exercised | - | - | - | 1 |
|---|
| Proceeds from right of first refusal liability | - | - | - | 25 |
|---|
| Proceeds from simple agreements for future equity | - | - | - | 10 |
|---|
| Payment of deferred issuance costs | 727,770 | - | - | 11 |
|---|
| Net cash provided by financing activities | 505 | - | -215,914,673 | 301 |
|---|
| Net increase in cash and cash equivalents | 3 | 240,309 | -1,948,667 | 87 |
|---|
| Income Taxes Paid | - | - | - | 1 |
|---|
| Reclassification of deferred issuance costs in connection with business combination | - | - | - | 6 |
|---|
| Reclassification of simple agreements for future equity in connection with business combination | - | - | - | 84 |
|---|
| Deferred issuance costs included in accounts payable | - | - | - | 2 |
|---|
| Capital Expenditures Incurred but Not yet Paid | - | - | - | 1 |
|---|